Effect of GHRH and peptides from the vasoactive intestinal peptide family on cAMP production of human cancer cell lines in vitro

Medicine & Life Sciences

• 9-(tetrahydro-2-furyl)-adenine 29%
• Adenylyl Cyclase Inhibitors 25%
• Adenylyl Cyclases 34%
• Breast 13%
• Cell Line 50%
• Cultured Tumor Cells 24%
• Glucagon 35%
• Growth 25%
• In Vitro Techniques 37%
• Insulin-Like Growth Factor II 21%
• Neoplasms 27%
• Neuropeptide Y 39%
• Peptides 54%
• Pertussis Toxin 19%
• PG 97-269 35%
• RMI 12330A 30%
• Second Messenger Systems 18%
• Secretin 43%
• somatotropin releasing hormone receptor 28%
• Vasoactive Intestinal Peptide 100%